Checkmate Pharmaceuticals Investors

48 investors on Angel Roster list Checkmate Pharmaceuticals in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, China and Canada.

Investors are matched on the company name in their portfolio, so companies that share the name Checkmate Pharmaceuticals can appear together.

Investors listed
48
With verified email
56%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 40 Checkmate Pharmaceuticals investors

The most complete profiles first. Showing 40 of 48.

  • Amar PatelVerified

    Venture Capital, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Annie MitsakVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Verified email available

  • Brian LiuVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Jon EdwardsVerified

    Venture Capital, Investor · United States

    SeedHealth CareHospitalsWomen FoundedEnergy

    Portfolio: Rondo Therapeutics, Gadeta, SuperX, Critical Pressure and 24 more

    Verified email available

  • Jonathan LeffVerified

    Venture Capital, Investor · United States

    SeedSeries BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more

    Verified email available

  • Karthik BolisettyVerified

    Venture Capital, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Michael WertVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Richard GasterVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Verified email available

  • Richard LeeVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    SeedHealth CareHospitalsE-commerceWomen Founded

    Portfolio: Gadeta, SuperX, Critical Pressure, Impact Biomedicines and 23 more

    Verified email available

  • Sarah BhagatVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Sonia ParekhVerified

    Venture Capital, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Victor TongVerified

    Venture Capital, Private Equity Firm · United States

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Verified email available

  • Alan ColowickVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • AnneVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Verified email available

  • Catherine PoulinVerified

    Private Equity Firm, Investment Partner · Canada

    Health CareInvestment ManagementLife ScienceEmerging Markets

    Portfolio: HighLife, CurvaFix, Aprea, F2G and 19 more

    Verified email available

  • Claire ChinVerified

    Venture Capital · China

    Health CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Verified email available

  • David GraingerVerified

    Venture Capital · United Kingdom

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: Gadeta, SuperX, Critical Pressure, Impact Biomedicines and 23 more

    Verified email available

  • David PezeshkiVerified

    Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Verified email available

  • Garrett HowardVerified

    Venture Capital · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Jason PittsVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Josh RichardsonVerified

    Venture Capital · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Mike PowellVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Paulina HillVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Verified email available

  • Qiang XuVerified

    Venture Capital · China

    Health CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Verified email available

  • Shyam M.Verified

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: Gadeta, SuperX, Critical Pressure, Impact Biomedicines and 23 more

    Verified email available

  • Wei XuVerified

    Venture Capital · China

    Health CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Verified email available

  • Aaron Royston, M.D.

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, HistoWiz and 35 more

    Contact details available

  • Dan Zabrowski

    Venture Capital, Private Equity Firm · United States

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Fang Yang

    Venture Capital, Private Equity Firm · China

    Early Stage VentureHealth CareInvestment ManagementChemicalLife Science

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Francesco Draetta

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Contact details available

  • Jaume Pons

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Contact details available

  • Katie Kerfoot

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Contact details available

  • Maha Katabi, PhD, CFA

    Hedge Fund, Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more

    Contact details available

  • Maxwell Bikoff

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Contact details available

  • Michelle Doig

    Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Contact details available

  • Nick Pliam

    Venture Capital, Private Equity Firm · United States

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Perry Nisen

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Weizhi (Aaron) Li

    Venture Capital, Private Equity Firm · China

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Y. Katherine Xu

    Venture Capital, Private Equity Firm · United States

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Yvonne Yamanaka

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Contact details available

See all 48 Checkmate Pharmaceuticals investors

Search, filter and unlock verified emails and LinkedIn profiles. Free to browse.

Frequently asked questions

How many Checkmate Pharmaceuticals investors are on Angel Roster?

Angel Roster lists 48 Checkmate Pharmaceuticals investors. 27 of them (56%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (44), Private Equity Firms (21) and Investment Partner Investors (3). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Checkmate Pharmaceuticals investors invest in?

Among those that list a stage, the most common are Seed (16), Early Stage Venture (6) and Series B (5).

Where are Checkmate Pharmaceuticals investors based?

Most are based in the United States (35), China (5) and Canada (4).

Which companies have Checkmate Pharmaceuticals investors backed?

The most-backed portfolio companies among them are Neurana Pharmaceuticals (20), Vera Therapeutics (20), Civitas Therapeutics (20), Polares Medical (20) and Inozyme (20).

How do I contact Checkmate Pharmaceuticals investors?

Create a free Angel Roster account to search and filter all 48, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.